Finland
July 03, 2018
:
VTT Technical Research Centre of Finland has developed a vaccine, diluted into drinking water, to treat diarrhoea on piglets being weaned.
Our Bureau, Mumbai
June 23, 2018
:
The bacillus Calmette-Guérin (BCG) vaccine is one of the oldest vaccines in the world, developed for tuberculosis (TB) protection and for early stage bladder cancer therapy. BCG is an attenuated version of the virulent
Our Bureau, Bengaluru
June 18, 2018
:
Blood donors across the country highlighted importance of voluntary blood donation to offset shortage of 70-75 per cent blood reserves.
Mumbai, India
June 12, 2018
:
MedGenome, a leading genomics driven research and diagnostics company, announced that it's OncoPep platform of advanced genomics-based solutions designed to accelerate cancer immune-oncology research,
Worcester, Massachusetts
June 11, 2018
:
WuXi Biologics, a leading global open-access biologics technology platform company, announced that it is to invest $60 million and hire approximately 150 employees to establish a state-of-the-art biologics
Guangzhou, China
June 09, 2018
:
GE Healthcare will provide Xiangxue Pharmaceutical Co., Ltd. (XPH) with a FlexFactory for cell therapy, a semi-automated end-to-end manufacturing platform, to help scale up, digitize and accelerate
Our Bureau, Bengaluru
June 08, 2018
:
Vetter Pharma International, a leading contract development and manufacturing organization, has launched the Open Innovation Challenge campaign to develop a future-focused and sustainable solutions for the
Cologne, Germany
June 05, 2018
:
Ayoxxa Biosystems GmbH, an international biotechnology company, announced the expansion of its catalogue of kits for fully scalable multiplex protein analysis with the introduction of Lunaris Human &
West Sussex, UK
June 04, 2018
:
BioIVT, a leading provider of biospecimens and related services, has announced that the Human Tissue Authority (HTA) has granted a satellite license to its West Sussex facility.
Yongin, South Korea
May 22, 2018
:
GC Pharma (formerly known as Green Cross Corporation), a South Korean bio pharmaceutical company, announced the establishment of Curevo Inc. (Curevo). The newly established Seattle-based company's